Title
Treatment of Drug-Resistant Tuberculosis
Authoring Organizations
Publication Month/Year
November 15, 2019
Last Updated Month/Year
February 21, 2024
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
Recommendations on drugs for use in a treatment regimen for patients with multidrug-resistant tuberculosis
Target Patient Population
Patients being evaluated and treated for any form of drug-resistant TB
Inclusion Criteria
Male, Female, Adolescent, Adult, Child, Older adult
Health Care Settings
Ambulatory, Hospital
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Treatment, Management
Diseases/Conditions (MeSH)
D014376 - Tuberculosis, D054908 - Extensively Drug-Resistant Tuberculosis
Keywords
multidrug-resistant (MDR), tuberculosis, Multidrug resistant, Tuberculosis
Source Citation
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. Am J Respir Crit Care Med 2019;200:e93–e142
Supplemental Methodology Resources
Methodology
Number of Source Documents
344
Literature Search Start Date
January 1, 2009
Literature Search End Date
September 15, 2015
/*=$parent_array_uuid*/ ?>">
/*=$parent_array_uuid*/ ?>">
/*=$parent_array_uuid*/ ?>">
/*=$parent_array_uuid*/ ?>">
/*=$parent_array_uuid*/ ?>">
Specialties Involved
Infectious Disease, Pathology, Pediatrics, Pulmonology, Medical Microbiology, Pediatric Infectious Diseases, Pediatric Pulmonology, Pathology, Pediatrics, Pediatrics
/*=$parent_array_uuid*/ ?>">
/*=$parent_array_uuid*/ ?>">
/*=$parent_array_uuid*/ ?>">
/*=$parent_array_uuid*/ ?>">
/*=$parent_array_uuid*/ ?>">
/*=$parent_array_uuid*/ ?>">
/*=$parent_array_uuid*/ ?>">
/*=$parent_array_uuid*/ ?>">
/*=$parent_array_uuid*/ ?>">
/*=$parent_array_uuid*/ ?>">
/*=$parent_array_uuid*/ ?>">